NDC 82922-023 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-023
- Package NDCs from labels
- 82922-023-01
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENTECAVIR - Truemed Group LLC | Truemed Group LLC | 2022-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ENTECAVIR | ENTECAVIR | Yaopharma Co., Ltd. | 73dea2a4-a596-477f-b66d-5a80dd019837 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | AvKARE | 5a1cbf7e-0352-aa3b-080c-222a6423ecd8 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| ENTECAVIR | ENTECAVIR | NorthStar RxLLC | da705339-c349-444f-a058-4f0cef2864bf | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | Golden State Medical Supply, Inc. | 20d62f1a-2e48-69dd-e063-6294a90ace31 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | EPIC PHARMA, LLC | af4f47e2-f556-40f2-a0fd-ff81e9f27429 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | Carlsbad Technology, Inc. | 1a905283-0057-a7dd-e063-6394a90a1909 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | Zydus Lifesciences Limited | 0e3b2a0a-9076-4907-bbaf-eb6a65bb9481 | 2024-11-28 | 5968Y6H45M | |
| Entecavir | ENTECAVIR | American Health Packaging | a0d2e00d-21f0-4449-93b7-a19fa284d51d | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | Aurobindo Pharma Limited | def332bf-2906-4a6c-b85d-dfb56bb94312 | 2023-11-23 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| Entecavir | ENTECAVIR | Zydus Pharmaceuticals USA Inc. | b4fd0e22-ad23-4f51-9b98-95182f63c2eb | 2023-10-05 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| ed8b5555-7119-651c-e053-2a95a90af4b9 | e5e6c5d5-a318-4080-e053-2a95a90a0f00 | 2022-11-15 | e5e6c5d5-a318-4080-e053-2a95a90a0f00 | |||
| Entecavir | ENTECAVIR | Amneal Pharmaceuticals LLC | 007a6ad8-4d23-4543-ae48-c651cac7dd7b | 2019-11-24 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
| BARACLUDE | ENTECAVIR | E.R. Squibb & Sons, L.L.C. | 046e61c9-9298-4b2e-b76e-b26b81fecd20 | 2019-11-06 | Boxed warning, Warnings, Adverse reactions | 5968Y6H45M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.